Arkema and Nippon Shokubai join forces to achieve mass production by end of 2025

Nippon Shokubai and Arkema are jointly conducting feasibility studies and forming a joint venture to build an industrial plant in France for the production of LiFSI (difluorosulfonyl), according to Arkema's official website.
Lithium imide) ultrapure electrolyte salt, which is expected to achieve mass production by the end of 2025
.

Ultrapure and high-performance LiFSI electrolyte salts are a key ingredient in automotive battery cells that will accelerate next-generation batteries (including Development of new electrolyte formulations for semi-solid and solid-state batteries)
.

The industrial project will support the development of the European battery value chain and participate in the global demand for carbon neutrality
.

Combining Arkema's fluorochemical expertise and Nippon Shokubai's unique expertise in the production of high-purity LiFSI on an industrial scale, the two parties have entered into a strategic partnership to develop innovative and integrated processes
.
Based on this cutting-edge patented technology, a LiFSI fluorination pilot line has been installed at the Pierre-Bénite plant and will be successfully commissioned in 2021
.

To support the exponential growth in demand for battery materials, Arkema and Nippon Shokubai are taking a step forward, conducting a feasibility study and establishing a joint venture to enable large-scale production at Arkema's Pierre-Bénite plant in France by the end of 2025 Production of LiFSI electrolyte salts
.